2:56 pm Vertex Pharm: FDA Approves KALYDECO (ivacaftor) for use in eight additional mutations that cause cystic fibrosis – HedgeChatter

2:56 pm Vertex Pharm: FDA Approves KALYDECO (ivacaftor) for use in eight additional mutations that cause cystic fibrosis

24 Feb

2:56 pm Vertex Pharm: FDA Approves KALYDECO (ivacaftor) for use in eight additional mutations that cause cystic fibrosis

Bystocknews stock, VRTX Comments Off

View todays social media effects on VRTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Vertex is hiring next, click here to view

Author